Skip to main navigation

How Urovant Sciences is Responding to COVID-19

Learn More
clear
Home
Home

Main navigation

  • About
  • Science
  • Patients
  • Investors
    • Investor Overview
    • News Releases
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Events and Presentations
    • Shareholder Services
    • Contact IR
  • Careers
  • Contact

Urovant Sciences is advancing urologic patient care through innovative development and licensing opportunities.

Change
Volume
52 Week High
52 Week Low
 

Urovant Sciences is a biopharmaceutical company advancing urologic patient care through development of innovative therapies and exceptional licensing opportunities.

Our goal is to be the leading specialty company, recognized and trusted by patients and providers for our commitment to urology and their well-being. Urologic conditions can have a major impact on daily life, with those affected often suffering in silence as their conditions are overlooked, misunderstood or not adequately treated. 

More than 30 million people in the U.S. live with the bothersome symptoms of overactive bladder (OAB). The FDA has recently approved Gemtesa® (vibegron) for the treatment of overactive bladder in adult patients.

Click here for more information.

Urovant Sciences is investigating vibegron, a ß3 adrenergic agonist, for the treatment of OAB in men with benign prostatic hyperplasia, and URO-902, a novel gene therapy, for the treatment of OAB. 

 
In The News

View All
December 23, 2020
Urovant Sciences Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
View Press Release
November 24, 2020
Urovant Sciences Announces Topline Data from Phase 2a Study of Vibegron for the Treatment of Irritable Bowel Syndrome (IBS) Pain Did Not Meet Primary Endpoint
View Press Release
November 19, 2020
Urovant Sciences Announces Positive Clinical Efficacy and Safety Data from Vibegron EMPOWUR Long Term Extension Study
View Press Release
Urovant Sciences Logo

Footer menu

To report an Adverse Event or Product Complaint, call 1-833-876-8268

Legal

  • Terms of Use
  • Privacy Policy
  • Community Guidelines
© Copyright 2021. UROVANT and UROVANT SCIENCES are trademarks of Urovant Sciences GmbH, registered in the U.S. and other countries. All other trademarks are the property of their respective owners.
US-UROV-2000082 (v2.0)